Groups

PharmaMics

1–30 of 528

0 selected

9/17/10

[Pharmamics] Findings May Lead to First Approved Treatment for Myelofibrosis

Myelofibrosis is a rare but serious disorder in which the bone marrow is replaced by scar tissue.

unread,

[Pharmamics] Findings May Lead to First Approved Treatment for Myelofibrosis

Myelofibrosis is a rare but serious disorder in which the bone marrow is replaced by scar tissue.

9/17/10

9/15/10

[Pharmamics] Scientists In Singapore Discover New Drug Against Malaria

Scientists from the Singapore Immunology Network (SIgN) of Singapore's Agency of Science,

unread,

[Pharmamics] Scientists In Singapore Discover New Drug Against Malaria

Scientists from the Singapore Immunology Network (SIgN) of Singapore's Agency of Science,

9/15/10

9/14/10

[Pharmamics] Rosuvastatin cuts risk of catching pneumonia, study finds

Patients taking AstraZeneca Plc's cholesterol-lowering medicine Crestor (Rosuvastatin) in a study

unread,

[Pharmamics] Rosuvastatin cuts risk of catching pneumonia, study finds

Patients taking AstraZeneca Plc's cholesterol-lowering medicine Crestor (Rosuvastatin) in a study

9/14/10

9/13/10

[Pharmamics] Avandia Continues to Face Scrutiny: Biotech's Latest Mishaps

GlaxoSmithKline's (GSK) diabetes drug Avandia is once again under regulatory scrutiny—this time

unread,

[Pharmamics] Avandia Continues to Face Scrutiny: Biotech's Latest Mishaps

GlaxoSmithKline's (GSK) diabetes drug Avandia is once again under regulatory scrutiny—this time

9/13/10

9/13/10

[Pharmamics] 9/13/2010 03:18:00 AM

-- Posted By PharmaMics to Pharmamics at 9/13/2010 03:18:00 AM

unread,

[Pharmamics] 9/13/2010 03:18:00 AM

-- Posted By PharmaMics to Pharmamics at 9/13/2010 03:18:00 AM

9/13/10

9/12/10

[Pharmamics] Dapagliflozin is a new drug for the treatment of type two diabetes

A strange drug, the premier in its class, gives added blood sugar dominate to mobile vulgus with

unread,

[Pharmamics] Dapagliflozin is a new drug for the treatment of type two diabetes

A strange drug, the premier in its class, gives added blood sugar dominate to mobile vulgus with

9/12/10

9/10/10

[Pharmamics] Potential new drug for neurodegenerative diseases

A research team has identified a small molecule that helps human cells get rid of the misfolded,

unread,

[Pharmamics] Potential new drug for neurodegenerative diseases

A research team has identified a small molecule that helps human cells get rid of the misfolded,

9/10/10

9/10/10

[Pharmamics] Promising Treatment for Metastatic Melanoma

Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an

unread,

[Pharmamics] Promising Treatment for Metastatic Melanoma

Researchers from the John Theurer Cancer Center at Hackensack University Medical Center played an

9/10/10

5/25/10

[Pharmamics] Heart Drugs Safe for Lungs

Medical tradition says that the beta blockers used to treat heart disease shouldn't be given to

unread,

[Pharmamics] Heart Drugs Safe for Lungs

Medical tradition says that the beta blockers used to treat heart disease shouldn't be given to

5/25/10

5/20/10

[Pharmamics] Trials begin on hepatitis C drug

The first human clinical trials have started on a new drug developed to treat infections caused by

unread,

[Pharmamics] Trials begin on hepatitis C drug

The first human clinical trials have started on a new drug developed to treat infections caused by

5/20/10

5/20/10

[Pharmamics] New theory of Alzheimer's explains drug failures

Brain plaques, long considered the chief killer of brain cells and the cause of Alzheimer's

unread,

[Pharmamics] New theory of Alzheimer's explains drug failures

Brain plaques, long considered the chief killer of brain cells and the cause of Alzheimer's

5/20/10

5/14/10

[Pharmamics] New drug type developed to kill lymphoma cells

Scientists have developed a new type of drug designed to kill non-Hodgkin lymphoma tumour cells. The

unread,

[Pharmamics] New drug type developed to kill lymphoma cells

Scientists have developed a new type of drug designed to kill non-Hodgkin lymphoma tumour cells. The

5/14/10

5/14/10

[Pharmamics] New drug may help MS patients walk

A new drug may make getting around easier for the 2.5 million people worldwide afflicted with

unread,

[Pharmamics] New drug may help MS patients walk

A new drug may make getting around easier for the 2.5 million people worldwide afflicted with

5/14/10

5/14/10

[Pharmamics] Risks of some acid-reducing drugs may outweigh benefits

More than 113 million prescriptions are written every year for proton pump inhibitors, drugs such as

unread,

[Pharmamics] Risks of some acid-reducing drugs may outweigh benefits

More than 113 million prescriptions are written every year for proton pump inhibitors, drugs such as

5/14/10

5/10/10

[Pharmamics] Potential new drug target to combat Kaposi's Sarcoma

Kaposi's Sarcoma is a cancer caused by a human herpes virus and is widespread in sub-Saharan

unread,

[Pharmamics] Potential new drug target to combat Kaposi's Sarcoma

Kaposi's Sarcoma is a cancer caused by a human herpes virus and is widespread in sub-Saharan

5/10/10

5/10/10

[Pharmamics] Drug-Eluting Peripheral Stent Continues to Show Positive Data at...

Patients treated with the Zilver® PTX™ Drug-Eluting Peripheral Stent maintained clinical improvement

unread,

[Pharmamics] Drug-Eluting Peripheral Stent Continues to Show Positive Data at...

Patients treated with the Zilver® PTX™ Drug-Eluting Peripheral Stent maintained clinical improvement

5/10/10

5/7/10

[Pharmamics] New drug offers hope to Celiac sufferers

Even if Janet Smith could give her 13-year-old daughter, Heather, a drug that would let her eat

unread,

[Pharmamics] New drug offers hope to Celiac sufferers

Even if Janet Smith could give her 13-year-old daughter, Heather, a drug that would let her eat

5/7/10

5/7/10

[Pharmamics] Osiris to resume enrollment in Crohn's drug study

Osiris Therapeutics Inc said it is resuming enrollment of patients in a clinical trial to study its

unread,

[Pharmamics] Osiris to resume enrollment in Crohn's drug study

Osiris Therapeutics Inc said it is resuming enrollment of patients in a clinical trial to study its

5/7/10

5/5/10

[Pharmamics] Magnetic stimulation of the brain can ease drug-resistant depres...

Daily application of magnetic stimulation to the brain for about 37 minutes can ease depression in

unread,

[Pharmamics] Magnetic stimulation of the brain can ease drug-resistant depres...

Daily application of magnetic stimulation to the brain for about 37 minutes can ease depression in

5/5/10

5/4/10

[Pharmamics] Parents Try Alternative Treatments for Autism

Many families are turning toward to special diets and/or psychotropic medications to help better

unread,

[Pharmamics] Parents Try Alternative Treatments for Autism

Many families are turning toward to special diets and/or psychotropic medications to help better

5/4/10

5/3/10

[Pharmamics] NDA Submitted for Azilsartan Medoxomil

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research &

unread,

[Pharmamics] NDA Submitted for Azilsartan Medoxomil

Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research &

5/3/10

5/3/10

[Pharmamics] Transplant drug 2-year study outcomes show superior kidney function

Two-year results from phase III clinical trials show the experimental immunosuppressive drug

unread,

[Pharmamics] Transplant drug 2-year study outcomes show superior kidney function

Two-year results from phase III clinical trials show the experimental immunosuppressive drug

5/3/10

5/3/10

[Pharmamics] FDA aprroves a new pain drug

Shares of Pozen Inc. surged more than 21% in the after hours trading session Friday after the US Food

unread,

[Pharmamics] FDA aprroves a new pain drug

Shares of Pozen Inc. surged more than 21% in the after hours trading session Friday after the US Food

5/3/10

5/1/10

[Pharmamics] Promise Seen in Drug for Fragile X Syndrome

An experimental drug succeeded in a small clinical trial in bringing about what the researchers

unread,

[Pharmamics] Promise Seen in Drug for Fragile X Syndrome

An experimental drug succeeded in a small clinical trial in bringing about what the researchers

5/1/10

5/1/10

[Pharmamics] Anabolic steroid users may face heart trouble

Bulking up with anabolic steroids appears to damage and weaken the heart, a new study shows, in

unread,

[Pharmamics] Anabolic steroid users may face heart trouble

Bulking up with anabolic steroids appears to damage and weaken the heart, a new study shows, in

5/1/10

5/1/10

[Pharmamics] Blood test helps target Roche/OSI lung cancer drug

Testing for specific cancer protein markers in lung cancer patients' blood helps find those more

unread,

[Pharmamics] Blood test helps target Roche/OSI lung cancer drug

Testing for specific cancer protein markers in lung cancer patients' blood helps find those more

5/1/10

4/30/10

[Pharmamics] A new drug target in lung cancer

Lung cancer patients whose tumors over-express a cell surface molecule called CXCR4 do significantly

unread,

[Pharmamics] A new drug target in lung cancer

Lung cancer patients whose tumors over-express a cell surface molecule called CXCR4 do significantly

4/30/10

4/30/10

[Pharmamics] Santaris Plans Phase II Trial of miRNA-Targeting HCV Drug

Santaris Pharma is close to completing a second phase I study of its microRNA-targeting hepatitis C

unread,

[Pharmamics] Santaris Plans Phase II Trial of miRNA-Targeting HCV Drug

Santaris Pharma is close to completing a second phase I study of its microRNA-targeting hepatitis C

4/30/10

4/30/10

[Pharmamics] Dendreon’s Provenge Approval Sparks New Era for Cancer Vaccines

Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a

unread,

[Pharmamics] Dendreon’s Provenge Approval Sparks New Era for Cancer Vaccines

Dendreon Corp. won approval for its only product, the prostate cancer vaccine Provenge, concluding a

4/30/10

4/30/10

[Pharmamics] Study sharpens focus on Glaxo's heart drug hope

A scientific study provided support on Friday for a way of fighting heart disease being pioneered by

unread,

[Pharmamics] Study sharpens focus on Glaxo's heart drug hope

A scientific study provided support on Friday for a way of fighting heart disease being pioneered by

4/30/10

Search

Clear search

Close search

Google apps

Main menu